Yali Zhai

ORCID: 0000-0001-9792-7336 · 4 papers in corpus
2026
·doi:10.1158/0008-5472.32675390

Quantification of IHC staining for STING conducted on a tumor microarray including cores from healthy FT, FT from patients with gynecological inflammation resulting from endometriosis or chronic salpingitis, and Stage I/Stage II HGSC

lab-animal 2025
Cancers ·doi:10.3390/cancers17172759

BACKGROUND/OBJECTIVES: High-grade serous carcinoma (HGSC) is the leading cause of ovarian cancer-related mortality. It usually arises from fallopian tube epithelium, with a smaller subset arising in non-tubal sites including the ovary or pe…

lab-animal 2016
The Journal of Pathology ·doi:10.1002/path.4599

Inactivation of the ARID1A tumour suppressor gene is frequent in ovarian endometrioid (OEC) and clear cell (OCCC) carcinomas, often in conjunction with mutations activating the PI3K-AKT and/or canonical Wnt signalling pathways. Prior work h…

lab-animal 2016
The Journal of Pathology ·doi:10.1002/path.4783

Endometrioid carcinoma (EC) is a relatively indolent ovarian carcinoma subtype that is nonetheless deadly if detected late. Existing genetically engineered mouse models (GEMMs) of the disease, based on transformation of the ovarian surface …